다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Beam Therapeutics Inc (BEAM)
Beam Therapeutics Inc (BEAM) 뉴스

BEAM

Beam Therapeutics (BEAM)

Beam Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BEAM

<< 이전 1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/12/14	20:30	GlobeNewswire Inc.	Beam Therapeutics Appoints Biotech Executive Christi Shaw to its Board of Directors	NASDAQ:BEAM	Beam Therapeutics Inc
2023/11/21	06:20	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BEAM	Beam Therapeutics Inc
2023/11/08	21:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BEAM	Beam Therapeutics Inc
2023/11/08	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BEAM	Beam Therapeutics Inc
2023/11/08	20:30	GlobeNewswire Inc.	Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results	NASDAQ:BEAM	Beam Therapeutics Inc
2023/11/08	20:30	GlobeNewswire Inc.	Beam Therapeutics to Participate in 2023 Jefferies London Healthcare Conference	NASDAQ:BEAM	Beam Therapeutics Inc
2023/11/02	05:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BEAM	Beam Therapeutics Inc
2023/10/31	19:59	Dow Jones News	Beam Therapeutics to Sell Rights in Verve Licensing Deal to Lilly for $250 Million Upfront	NASDAQ:BEAM	Beam Therapeutics Inc
2023/10/31	19:44	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BEAM	Beam Therapeutics Inc
2023/10/31	19:00	GlobeNewswire Inc.	Beam Announces Agreement for Lilly to Acquire Beam’s Opt-In Rights to Verve Therapeutics’ Base Editing Programs for Cardiovascular Disease	NASDAQ:BEAM	Beam Therapeutics Inc
2023/10/31	05:41	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BEAM	Beam Therapeutics Inc
2023/10/25	19:30	GlobeNewswire Inc.	Beam Therapeutics Presents Preclinical Data Highlighting Utility and Durability of BEAM-301 to Correct a Glycogen Storage Disease Type I Deficiency Disease-Causing Mutation at ESGCT	NASDAQ:BEAM	Beam Therapeutics Inc
2023/10/25	05:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BEAM	Beam Therapeutics Inc
2023/10/19	21:50	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BEAM	Beam Therapeutics Inc
2023/10/19	21:45	GlobeNewswire Inc.	Beam Therapeutics Announces Portfolio Prioritization and Strategic Restructuring Focused on Potential Near-term Value Drivers and Long-term Growth of Precision Genetic Medicines Pipeline	NASDAQ:BEAM	Beam Therapeutics Inc
2023/10/05	05:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BEAM	Beam Therapeutics Inc
2023/09/07	23:00	GlobeNewswire Inc.	Beam Therapeutics Presents Preclinical Data Highlighting Utility of BEAM-302 to Correct an Alpha-1 Antitrypsin (AAT) Deficiency Disease-Causing Mutation	NASDAQ:BEAM	Beam Therapeutics Inc
2023/09/05	19:30	GlobeNewswire Inc.	Beam Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of BEAM-201 in Relapsed, Refractory T-ALL/T-LL	NASDAQ:BEAM	Beam Therapeutics Inc
2023/08/31	19:30	GlobeNewswire Inc.	Beam Therapeutics to Participate in Upcoming September Investor Conferences	NASDAQ:BEAM	Beam Therapeutics Inc
2023/08/10	05:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BEAM	Beam Therapeutics Inc
2023/08/08	20:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BEAM	Beam Therapeutics Inc
2023/08/08	20:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BEAM	Beam Therapeutics Inc
2023/08/08	19:30	GlobeNewswire Inc.	Beam Therapeutics Reports Pipeline Updates and Second Quarter 2023 Financial Results	NASDAQ:BEAM	Beam Therapeutics Inc
2023/07/26	07:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BEAM	Beam Therapeutics Inc
2023/07/22	07:31	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BEAM	Beam Therapeutics Inc
2023/06/09	05:56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BEAM	Beam Therapeutics Inc
2023/06/09	05:53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BEAM	Beam Therapeutics Inc
2023/06/09	05:52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BEAM	Beam Therapeutics Inc
2023/06/09	05:50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BEAM	Beam Therapeutics Inc
2023/06/09	05:32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BEAM	Beam Therapeutics Inc

검색 관련기사 보기:NASDAQ:BEAM

<< 이전 1 2 3 4 5 6 7 8 9 10 다음 >>

Health Care Select Sector

Invesco QQQ Trust Series 1

Verizon Communications

Financial Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관